HR 8641
117th Congress
House
Health
Orphan Drug COVID–19 Mitigation Act of 2022
Introduced: August 2, 2022
Introduced by:
Gottheimer, Josh
Democratic
· New Jersey
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 2, 2022
Referred to the House Committee on Energy and Commerce.
Aug 2, 2022
Introduced in House
Plain-English summary
Orphan Drug COVID-19 Mitigation Act of 2022
This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1